¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Disorder of glycoprotein metabolism, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® bipolar disorder ÇÑ±Û ¾ç±Ø¼º Àå¾Ö
¼³¸í   
  ¿ÜºÎÀڱؿ¡ ÀÇÇØ¼­ º¯È­ÇÏÁö ¾Ê´Â Áö¼ÓÀûÀΠ¸¶À½ÀÇ »óÅÂÀΠ±âºÐ(mood)¿¡ ÀÌ»óÀÌ Àִ Á¤µ¿Àå¾ÖÀÇ ÇÑ Á¾·ù. Á¤µ¿Àå¾ÖÀÇ ´ëÇ¥ÀûÀΠÁúȯÀ¸·Î´Â ¿ÜºÎÀÇ Àڱؿ¡ °ü°è¾øÀÌ ±âºÐÀÌ ¿ì¿ïÇÑ ¿ì¿ïÁõ(depression)°ú Áö¼ÓÀûÀ¸·Î ¿ÜºÎÀÇ Àڱؿ¡ °ü°è¾øÀÌ Áö¼ÓÀûÀ¸·Î ±âºÐÀÌ µé¶ß´Â Á¶Áõ(mania)ÀÌ ÀÖ´Ù. ¿ì¿ïÁõ°ú Á¶ÁõÀÌ ÁÖ±âÀûÀ¸·Î ¹Ýº¹ÀÌ µÇ´Â Á¤½ÅÁúȯ°ú Á¶Áõ¸¸ ÀÖ°í ¿ì¿ïÁõÀº ¾ø´Â °æ¿ì¸¦ ¸ðµÎ Æ÷ÇÔÇϴ °³³äÀÌ´Ù.
¿µ¹® language disorder ÇÑ±Û ¾ð¾îÀå¾Ö
¼³¸í   
  ¸»À» ¹Ù¸£°Ô ¹ßÀ½ÇÏÁö ¸øÇϰųª Á¤È®ÇϰԠÀÌÇØÇÏÁö ¸øÇϴ º´Áõ. ±³Åë¼ö´ÜÀ¸·Î¼­ÀÇ ¾ð¾î·Î Á¤º¸¸¦ Àü´ÞÇϴµ¥ À־ÀÇ Àå¾ÖÀÌ´Ù. ¾ð¾î¸¦ ÀÌÇØ, Ç¥ÃâÇϴ »ý¸®ÇÐÀû, ½É¸®ÇÐÀû, ¾ð¾îÇÐÀû, ¹°¸®ÇÐÀû, »çȸÇÐÀûÀΠ°¢ °úÁ¤¿¡¼­ÀÇ Áúº´À̳ª Àå¾Ö·Î ÀÎÇØ ÀϾ¸ç ±× ¿øÀÎÀ̳ª º´Å¿¡ µû¶ó ±¸À½Àå¾Ö, ¸»´õµë, À½¼ºÀå¾Ö, ¾ð¾î¹ß´ÞÁöü, Ã»·ÂÀå¾Ö, ¼±Ãµ±âÇü µî ¸¹Àº Áúº´, Àå¾Ö·Î ¼¼ºÐµÈ´Ù. ¿øÀΠ¹× º´ÅÂÀÇ °Ë»ç, Áø´Ü¿¡´Â ³»°ú, À̺ñÀÎÈİú, Á¤½Å°ú, Ä¡°ú µî ¿©·¯ °ú¸ñ¿¡ °ÉÃÄ Á¤¹ÐÁ¶»ç¸¦ ÇÔ°ú µ¿½Ã¿¡ ¾ð¾î±â´É°Ë»ç¸¦ ÇؾߠÇÑ´Ù.
¿µ¹® personality disorder ÇÑ±Û ÀΰÝÀå¾Ö, ¼º°ÝÀå¾Ö
¼³¸í   
  Å¸°í³­ Àμº°ú ¼ºÀå°úÁ¤ÀÇ ¿©·¯ »ç°Ç, ±×¸®°í ±³À°Á¤µµ¿¡ µû¶ó °³ÀÎÀÇ ÀΰÝÀº Çü¼ºµÈ´Ù. ÀÌ·± ÀΰÝ(¼º°Ý)ÀÌ »çȸ»ýȰ, È¤Àº °¡Á·»ýȰ¿¡ ÁöÀåÀ» Áְųª, ÀÚ±âÀÚ½ÅÀÇ »ýȰ¿¡ ÇÇÇØ¸¦ Áִ °æ¿ì, À̸¦ ÀΰÝÀå¾Ö¶ó ºÎ¸¥´Ù. ½ÇÁ¦·Î ÀÌ·± ÀÏ·ÃÀÇ ¼º°ÝµéÀº ´©±¸³ª Á¤»óÀûÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖÀ¸³ª, À̻󼺰ÝÀÌ ½ÉÇÑ °æ¿ì Ä¡·áÀÇ ´ë»óÀÌ µÈ´Ù.
¿µ¹® narcissistic personality disorder ÇÑ±Û ÀÚ±â¾ÖÀû ÀΰÝÀå¾Ö
¼³¸í   
  ÀÚ½ÅÀÇ Á߿伺°ú µ¶Æ¯ÇÔ, À¯ÀÏÇÔ¿¡ ´ëÇÑ ±¤ÀûÀΠÁýÂø°ú ÀÚ½ÅÀÌ ¼º°øÇÒ °ÍÀ̶ó´Â Áö³ªÄ£ ÁýÂøÀ» º¸¿©Áִ ¼º°ÝÀå¾Ö. Áö³ªÄ£ Àڱ⿡ÀÇ ¸¸Á·°¨À» °¡Áö°í, Áö³ªÄ£ Àڽۨ, ¼º°ø¿¡ ´ëÇÑ È®½ÅÀ» Áö´Ï°í ÀÖ´Ù.
¿µ¹® conversion disorder ÇÑ±Û ÀüȯÀå¾Ö
¼³¸í   
  ³»ºÎÀÇ °¥µî¿¡ ´ëÇÑ ¹«ÀǽÄÀû ¹æ¾î¸ÞÄ¿´ÏÁòÀ¸·Î ³»ºÎÀÇ °¥µîÀ» Æ¯Á¤ÇÑ ½ÅüÀÇ Áõ»óÀ¸·Î º¯È¯ÇÏ¿© ³ªÅ¸³»´Â °ÍÀ» ¸» ÇÑ´Ù. ÀÌ ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ» ÁַΠ³ªÅ¸³»´Â Á¤½ÅÁúȯÀ» ÀüȯÀå¾Ö¶ó°í ÇÑ´Ù. ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ¸·Î ´ëÇ¥ÀûÀΠ°ÍÀ¸·Î´Â ¸¶ºñ, °æ·Ã, ÀǽÄÀå¾Ö µîÀÌ´Ù. ´ë°³ ±× º´À» ÀÏÀ¸Å³ ¸¸ÇÑ º´º¯ÀÌ Á¸ÀçÇÏÁö ¾Ê°í, ½É¸®Àû °¥µîÀÌ ½ÉÇÒ °æ¿ì¿¡ ´õ¿í Áõ»óÀÌ ½ÉÇØÁö°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇØ¼­ ³»ºÎÀû °¥µîÀÌ °¨¼ÒµÇ°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇÑ 2Â÷Àû À̵æ(°¡Á·µéÀÇ °ü½ÉÁýÁß, µ¹ºÁÁÜ)ÀÌ Àִ °ÍÀÌ ÀÌ ÀüȯÀå¾ÖÀǠƯ¡ÀÌ´Ù. ´ë°³ ÀÌ ÀüȯÀå¾Ö È¯Àڴ ÀÚ½ÅÀÇ Áúȯ¿¡ ´ëÇØ¼­ Æ¯Â¡ÀûÀ¸·Î ¸Å¿ì ¹«°ü½ÉÇѠŵµ¸¦ ÃëÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inborn errors of metabolism
    ¼±Ãµ´ë»çÀå¾Ö
  • metabolism
    ´ë»ç
  • microbial metabolism
    ¹Ì»ý¹°´ë»ç
  • peak metabolism
    ÃÖ´ë´ë»ç
  • antisocial personality disorder
    ¹Ý»çȸÀûÀΰÝÀå¾Ö
  • anxiety disorder
    ºÒ¾ÈÀå¾Ö
  • anxious personality disorder
    ºÒ¾ÈÀΰÝÀå¾Ö
  • articulation disorder
    ¹ßÀ½Àå¾Ö
  • asocial personality disorder
    ºñ»çȸÀûÀΰÝÀå¾Ö
  • attention deficit disorder
    ÁÖÀǷ°áÇÌÀå¾Ö
  • attention deficit hyperactivity disorder
    ÁÖÀǷ°áÇ̰ú´ÙȰµ¿Àå¾Ö
  • auditory disorder
    û°¢Àå¾Ö, ³­Ã»
  • autistic disorder
    ÀÚÆóÀå¾Ö, ÀÚÆóº´
  • autoimmune disorder
    ÀÚ°¡¸é¿ªÁúȯ
  • autosomal dominant disorder
    º¸Åë¿°»öü¿ì¼ºÁúȯ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
  • coordination disorder
    Çùµ¿Àå¾Ö
  • delusional disorder
    ÆíÁýÀå¾Ö, ÆíÁýº´
  • impulse control disorder
    Ãæµ¿Á¶ÀýÀå¾Ö, Ãæµ¿Á¶Àýº´
  • language disorder
    ¾ð¾îÀå¾Ö
  • learning disorder
    ÇнÀÀå¾Ö
  • metabolic disorder
    ´ë»çÀå¾Ö
  • neuromuscular disorder
    ½Å°æ±ÙÀ°Àå¾Ö, ½Å°æ±ÙÀ°Áúȯ
  • obsessive-compulsive disorder
    °­¹ÚÀå¾Ö, °­¹Úº´
  • oppositional defiant disorder
    Àû´ëÀû¹ÝÇ×Àå¾Ö
  • panic disorder
    °øÈ²Àå¾Ö, °øÈ²º´
  • paranoid disorder
    (¢¡delusional disorder) ÆíÁýÀå¾Ö, ÆíÁýº´
  • personality disorder
    ÀΰÝÀå¾Ö, ¼º°ÝÀå¾Ö
  • phonation disorder
    ¹ß¼ºÀå¾Ö
  • platelet function disorder
    Ç÷¼ÒÆÇ±â´ÉÀÌ»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • adjustment disorder
    ÀûÀÀÀå¾Ö
  • affective disorder
    Á¤µ¿Àå¾Ö, Á¤µ¿º´
  • amnestic disorder
    ±â¾ï»ó½ÇÀå¾Ö
  • anankastic personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • antisocial personality disorder
    ¹Ý»çȸÀΰÝÀå¾Ö
  • anxiety disorder
    ºÒ¾ÈÀå¾Ö
  • anxious personality disorder
    ºÒ¾ÈÀΰÝÀå¾Ö
  • articulation disorder
    ÀÔ¼Ò¸®Àå¾Ö, ¹ßÀ½Àå¾Ö
  • asocial personality disorder
    ºñ»çȸÀΰÝÀå¾Ö
  • auditory disorder
    û·ÂÀå¾Ö, ³­Ã»
  • autistic disorder
    ÀÚÆóÀå¾Ö, ÀÚÆóº´
  • autosomal dominant disorder
    º¸Åë¿°»öü¿ì¼ºÁúȯ
  • autosomal recessive disorder
    º¸Åë¿°»öü¿­¼ºÁúȯ
  • avoidant personality disorder
    ȸÇÇÀΰÝÀå¾Ö
  • behavior disorder
    ÇൿÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • purine metabolism
    Ç»¸°´ë»ç(¡­ÓÛÞó).
  • purine metabolism
    Ç»¸°(Ǫ¸°)´ë»ç(¡­ÓÛÞó)
  • Body dysmorphic disorder
    ½ÅüÀÌÇüÀå¾Ö(º´)
  • PDDs Pervasive Developmental Disorder
    Àü¹ÝÀû ¹ß´ÞÀå¾Ö
  • PTSD.see Post Traumatic Stress Disorder
    ¿Ü»óÈÄ ½ºÆ®·¹½ºÀå¾Ö(º´)
  • REM sleep behavior disorder
    ·½¼ö¸éÇൿÀå¾Ö(º´)
  • Retts disorder
    ·¹Æ®Àå¾Ö, ·¹Æ®º´
  • SAD, see seasonal affective disorder
    °èÀý¼º Á¤µ¿Àå¾Ö(º´)
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö (¡­Òàî¡äô).
  • acute polymorphic psychotic disorder
    ±Þ¼º ´ÙÇü¼º Á¤½ÅÁõÀû Àå¾Ö(º´)
  • acute stress disorder
    ±Þ¼º ½ºÆ®·¹½º Àå¾Ö(º´)
  • adjustment disorder
    ÀûÀÀÀå¾Ö(º´)
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö(º´), ¼ö¸é Á¶Á¤ Àå¾Ö(º´)
  • affective disorder
    °¨µ¿¼º Á¤½Åº´, Á¤µ¿¼º Á¤½ÅÀå¾Ö(¡­ïñãêî¡äô).
  • allergic disorder
    ¾Ë·¹¸£±â(¼º) Áúȯ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bone mineral metabolism
    °ñ ¹«±âÁú ´ë»ç(ÍéÙíѦòõÓÛÞó), °ñ ±¤¹°(Áú) ´ë»ç.
  • bone mineral metabolism
    °ñ±¤¹°(Áú)´ë»ç.
  • calcium metabolism
    Ä®½·´ë»ç(¡­ÓÛÞó)
  • calcium/phosphate metabolism
    Ä®½·/Àλ꿰 ´ë»ç
  • calcium/phosphorus metabolism
    Ä®½·/Àδë»ç
  • carbohydrate metabolism
    ź¼öÈ­¹°´ë»ç
  • constructive metabolism = ananolism
    º¸°­´ë»ç.
  • drug metabolism
    ¾à¹°´ë»ç
  • drug metabolism
    ¾à¹°´ë»ç.
  • electrolyte metabolism
    ÀüÇØÁú´ë»ç(¡­ÓÛÞó).
  • energy metabolism
    ¿¡³ÊÁö´ë»ç.
  • energy metabolism
    ¿¡³ÊÁö´ë»ç(ÓÛÞó)
  • error of metabolism
    ´ë»ç(ÓÛÞó)ÀÌ»ó.
  • erythrocyte metabolism
    ÀûÇ÷±¸ ´ë»ç
  • exogenous metabolism
    ¿ÜÀμº ´ë»ç.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DD dangerous drug; data definition; day of delivery; degenerated disc; degenerative disease; delusional...
PAD pain and distress; patient surface axis depth; percutaneous abscess drainage; percutaneous automated...
SPD schizotypal personality disorder; sociopathic personality disorder; specific paroxysmal discharge; s...
ADME [drug] absorption, distribution, metabolism, and excretion
BM Bachelor of Medicine; barium meal; basal medium; basal metabolism; basement membrane; basilar membra...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
"M" metabolism
ASD Acute Stress Disorder
AD Affective disorder
AUD Alcohol Use Disorder
AUDIT Alcohol Use Disorder Identification Test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • microbial metabolism
    ¹Ì»ý¹°ÀÇ ´ë»ç
  • mineral metabolism
    ±¤¹°Áú ´ë»ç, ¹«±âÁú ´ë»ç
  • peak metabolism
    Á¤´ë»ç
  • phosphorus metabolism
    ÀÎ ´ë»ç
  • potassium metabolism
    Æ÷Ÿ½Ã¿ò ´ë»ç
  • salt metabolism
    ¿°·ù ´ë»ç
  • acquired disorder
    ÈÄõ¼º Àå¾Ö
    ¼±ÃµÀûÀÌ ¾Æ´Ï°í Ãâ»ý ÈÄ Á¤»óÀûÀÎ ¹ßÀ°¿¡ ÀÌ»óÀÌ »ý±â°Å³ª, º¯È­°¡ ¿À°Å³ª, Àå¾Ö°¡ ÀϾ °Í.
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö
  • adjustment disorder
    ÀûÀÀÀå¾Ö, ÀûÀÀÀå¾Ö º´
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö, ÀûÀÀ¼º ¼ö¸éÀå¾Ö º´, ¼ö¸é Á¶Á¤ Àå¾Ö, ¼ö¸é Á¶Á¤ Àå¾Ö º´
  • affective disorder
    Á¤µ¿Àå¾Ö
  • antisocial personality disorder
    ¹Ý»çȸÀû ÀÎ°Ý Àå¾Ö
  • anxiety disorder
    ºÒ¾È Àå¾Ö
    °­¹ÚÁõ, ¿Ü»ó ÈÄ ½ºÆ®·¹½ºÀå¾Ö, °øÆ÷Áõ, °øÈ²Àå¾Ö¸¦ Æ÷ÇÔÇÏ´Â ³ÐÀº ÀǹÌÀÇ ½É¸®Àû Áúº´À¸·Î¼­ ºÒ¾È¿¡ ´ëÇÑ ºñÇö½ÇÀûÀ̰í Áö¼ÓÀûÀÎ ´À³¦, ºÒÈ®½Ç¼º, ¹Ì·¡ÀÇ ¿ì·Á³ª À§Çè¿¡ ´ëÇÑ µÎ·Á¿òÀÌ Æ¯Â¡À̸ç, ±äÀå°¨À̳ª ºÒ¾ÈÀ» µ¿¹ÝÇÑ´Ù. À̰ÍÀº ÀûÀÀ ±â´ÉÀÌ Á¦ÇѵǸç, ȯÀÚ¸¦ ¾È½É½Ã۸é Áõ»óÀÌ ¿ÏÈ­µÈ´Ù.
  • articular disorder
    °üÀý Àå¾Ö
  • atypical factitious disorder
    ºñÁ¤Çü °¡À强 Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
inborn errors of metabolism Term coined by A. Garrod in 1908 applying to heritable disorders of biochemistry. Examples include albinism, cystinuria (a cause of kidney stones) and phenylketonuria (pku) are a few of the hundreds of inborn errors of metabolism.
(12 Dec 1998)
intermediary metabolism Enzyme-catalysed processeswithin cells that extract energy from nutrientmolecules and use that energy to construct cellular components.
(09 Oct 1997)
iron metabolism disorders Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization.
(12 Dec 1998)
oxidative metabolism Respiration in the biochemical sense.
(18 Nov 1997)
electrolyte metabolism The chemical changes that various essential minerals (e.g., sodium, potassium, calcium, magnesium) undergo in the tissues.
(05 Mar 2000)
energy metabolism Those metabolic reactions whose role is to release or to provide energy.
(05 Mar 2000)
fat metabolism Oxidation, decomposition, and synthesis of fats in the tissues.
(05 Mar 2000)
fructose metabolism, inborn errors Inherited abnormalities of fructose metabolism, which include three known autosomal recessive types: hepatic fructokinase deficiency (essential fructosuria), hereditary fructose intolerance, and hereditary fructose-1,6-diphosphatase deficiency. Essential fructosuria is a benign asymptomatic metabolic disorder caused by deficiency in fructokinase, leading to decreased conversion of fructose to fructose-1-phosphate and alimentary hyperfructosaemia, but with no clinical dysfunction; may produce a false-positive diabetes test.
(12 Dec 1998)
a1-acid glycoprotein <biology> Plasma protein of mammals and birds, 38% carbohydrate. In humans a single chain glycoprotein of 39 kD. Increased levels are associated with inflammation, pregnancy and various diseases.
(18 Nov 1997)
acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase <enzyme> Forms oligosaccharide core class 3 (glcnac beta 1-3galnac) in mucins and various glycoproteins
Registry number: EC 2.4.1.147
Synonym: udp-glcnac-galnac-r beta 3-acetylglucosaminyltransferase, agggag-transferase
(26 Jun 1999)
amyloidogenic glycoprotein <protein> An integral membrane glycoprotein of the brain and related to the Drosophila vnd gene product. A precursor of _ amyloid, that accumulates in Alzheimer's disease and Down's syndrome.
See: amyloid precursor protein.
(18 Nov 1997)
b2-glycoprotein II <enzyme> A glycine-rich, heat-labile beta-glycoprotein found in blood. It is a proactivator of complement 3 in the alternate pathway of complement activation. Factor b is converted by factor d to c3 convertase.
Registry number: EC 3.4.21.47
(12 Dec 1998)
beta-1,3-galactosyl-0-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase <enzyme> Capable of adding a glcnac residue to g1cnacman(3)g1cnac; from mung bean seedlings
Registry number: EC 2.4.1.146
Synonym: n-acetylglucosaminyltransferase II, gal3-(glcnac6)galnac-mucin (glcnac--gal)3-glcnactransferase
(26 Jun 1999)
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-acetylglucosaminyl transferase <enzyme> With EC 2.4.1.148 this is called beta6-glcnac-transferase b
Registry number: EC 2.4.1.102
Synonym: gal3-galnac-mucin-6-glcnac transferase, udp-glcnac-gal1-3galnac-r-(glcnac to galnac)-beta1-6glcnac transferase, core 2 glcnac transferase, core 2-n-acetylglucosaminyltransferase, core 2 beta6-gn-t
(26 Jun 1999)
beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase <enzyme> Induced in preneoplastic stage of liver carcinogenesis promoted by orotic acid in rats; adds "bisecting n-acetylglucosaminyl residue in beta 1,4 linkage to the beta-linked mannose of the core of asparagine-linked oligosaccharides
Registry number: EC 2.4.1.144
Synonym: n-acetylglucosaminyltransferase III, udpgnac-glycopeptide beta4-n-acetylglucosaminyl transferase III, udpgnac-magtransferase III, udp-n-acetylglucosamine-beta-d-mannoside beta-1,4-n-acetylglucosaminyltransferase III
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á